טוען...
Cyclooxygenase‐2 expression correlates with poor prognosis in pancreatic cancer
BACKGROUND: Cyclooxygenase‐2 (COX‐2) overexpression is related to poor outcome in several cancers. COX‐2 is upregulated in 42–90% of pancreatic ductal adenocarcinomas and is a potential target for chemotherapy. Earlier studies have not shown the expression of COX‐2 to be a prognostic factor in pancr...
שמור ב:
| Main Authors: | , , , , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
BMJ Group
2006
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC1860358/ https://ncbi.nlm.nih.gov/pubmed/16467169 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/jcp.2005.026831 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|